This week, GSK won a much-needed victory in a $640 million cancer lawsuit over the heartburn drug Zantac. However, thousands of lawsuits are still due to go to trial in the US. And there are thousand…
Substack is the home for great culture
This week, GSK won a much-needed victory in a $640 million cancer lawsuit over the heartburn drug Zantac. However, thousands of lawsuits are still due to go to trial in the US. And there are thousand…